Webcast presentation following the voluntary hold of clinical studies with masitinib
08/06/2021 : Presentation of the webcast that was held following the voluntary hold of clinical studies with masitinib
Live webcast on Thursday June 3, 2021 following the voluntary hold in the clinical studies of masitinib
02/06/2021 – AB Science will host a live webcast on June 3, 2021 to provide details on the decision to suspend voluntarily the clinical studies with masitinib
AB Science announces a voluntary hold in the clinical studies of masitinib
01/06/2021 – AB Science announced today that it has taken the decision to suspend inclusions and treatment initiation in its clinical studies with masitinib worldwide
Results from Phase 3 study evaluating masitinib in prostate cancer
26/05/2021 – AB Science communicated the results from Phase 3 study evaluating masitinib in prostate cancer during the webcast that was held on May 25, 2021
Masitinib in Prostate Cancer Webcast Presentation
25/05/2021 – Presentation of the webcast held on May 25, 2021 on masitinib in prostate Cancer Download PDF
Live webcast on Tuesday May 25, 2021 on masitinib’s results in prostate cancer
21/05/2021 – AB Science will host a live webcast on May 25, 2021 to discuss recently reported results from the Phase 2B/3 masitinib trial in prostate cancer
Results from masitinib study AB12005 in pancreatic cancer selected for presentation at the ASCO Annual Meeting
20/05/2021 – AB Science today announced that results from masitinib study AB12005 in pancreatic cancer, have been selected for presentation at the upcoming ASCO Annual Meeting
Annual financial results as of 31 December, 2020
30/04/2021 – AB Science reports its annual financial results as of 31 December, 2020
Masitinib Phase 2B/3 study in prostate cancer met its primary endpoint
29/04/2021 – AB Science today announces that its masitinib Phase 2B/3 study (AB12003) in metastatic castrate-resistant prostate cancer (mCRPC) met its predefined primary endpoint
AB Science secures 6M€ in non-dilutive financing guaranteed by the French Government
14/04/2021 – AB Science today announces that it has received financing approval from Société Générale, Bpifrance and Banque Populaire for a total of EUR 6 million in the form of state-guaranteed loans